Effects of M184V mutation in multi-dideoxynucleoside analog resistant HIV-1 reverse transcriptase on removal of β-D-dioxolane-guanine monophosphate from blocked primer

被引：0
|
作者：
Lennerstrand, J
Espili, NH
Pavlova, A
Chu, CK
Asif, G
Schinazi, RF
机构：
[1] Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden
[2] Univ Georgia, Coll Pharm, Athens, GA 30602 USA
[3] Emory Univ, VA Med Ctr, Decatur, GA 30033 USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 15 条
  • [1] Effects of M184V mutation in multi-dideoxynucleoside analog resistant HIV-1 reverse transcriptase on removal of β-D-dioxolane-guanine monophosphate from blocked primer
    Lennerstrand, J
    Espili, NH
    Pavlova, A
    Chu, CK
    Asif, G
    Schinazi, RF
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S79 - S79
  • [2] Decreased rates of transmission of drug-resistant HIV-1 strains containing the M184V mutation in reverse transcriptase
    Turner, D
    Brenner, BG
    Routy, JP
    Moisi, D
    Wainberg, MA
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : U123 - U124
  • [3] Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis
    Wei, X
    Liang, C
    Götte, M
    Wainberg, MA
    [J]. VIROLOGY, 2003, 311 (01) : 202 - 212
  • [4] The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses
    Wei, X
    Liang, C
    Götte, M
    Wainberg, MA
    [J]. AIDS, 2002, 16 (18) : 2391 - 2398
  • [5] Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors
    Catucci, M
    Venturi, G
    Romano, L
    Riccio, ML
    De Milito, A
    Valensin, PE
    Zazzi, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (03): : 203 - 208
  • [6] The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine
    Sprout, M
    Pozniak, AL
    Peeters, M
    Winters, B
    Hoetelmons, R
    Graham, NM
    Gazzard, BG
    [J]. ANTIVIRAL THERAPY, 2005, 10 (02) : 357 - 361
  • [7] Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV-1 Reverse Transcriptase
    von Wyl, Viktor
    Ehteshami, Maryam
    Symons, Jori
    Buergisser, Philippe
    Nijhuis, Monique
    Demeter, Lisa M.
    Yerly, Sabine
    Boeni, Juerg
    Klimkait, Thomas
    Schuurman, Rob
    Ledergerber, Bruno
    Goette, Matthias
    Guenthard, Huldrych F.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (07): : 1054 - 1062
  • [8] Reverse transcriptase mutation M184V delays the selection of thymidine-analogue mutations in children infected with subtype-C HIV-1
    Averbuch, D
    Schapiro, JM
    Engelhard, D
    Gradstein, S
    Gottesman, G
    Kedem, E
    Einhorn, M
    Grisaru-Soen, G
    Ofir, M
    Milguir, F
    Rudich, H
    Ram, D
    Grossman, Z
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U114 - U115
  • [9] Effects of mutations associated with suppression of zidovudine resistance in HIV-1 reverse transcriptase on removal of tenofovir from blocked primer/template
    Espili, NH
    Bergroth, T
    Pavlova, A
    Shao, XW
    McKenna, P
    Sönnerborg, A
    Lennerstrand, J
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U36 - U37
  • [10] Elucidating the molecular interactions of the <it>L</it>-nucleotide analogs with the Complex of HIV-1 Reverse Transcriptase and DNA and the mechanism of drug resistance conferred by the M184V mutation
    Suo, Zucai
    [J]. FASEB JOURNAL, 2020, 34
12